ALIVE Israel Healthtech Fund is a mid-to-late-stage healthtech investment fund that operates through a strategic partnership model to support the clinical and commercial expansion of its portfolio companies.

The fund focuses on Medtech, Digital Health, and Bio Convergence, with a strong emphasis on the U.S. market and global outreach.

By collaborating with hospital chains, HMOs, financial institutions, venture capital firms, and crossover funds, the fund facilitates regulatory progress, business plan execution, and strategic growth for its portfolio companies.